Le Lézard
Classified in: Health
Subject: AWD

Cathy Bucci-Griffin RN., BSc. is recognized by Continental Who's Who


CHICAGO, Feb. 14, 2018 /PRNewswire/ -- Cathy Bucci-Griffin RN., BSc. is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare in recognition of her role as an Oncology Healthcare Consultant.

As former Regional Director of Operations at Mckesson Specialty Health, Cathy currently works with Affiliated Oncologists LLC. The practice consists of strong community based centers with 7 sites of service. With 26 healthcare providers specializing in various medical areas, Affiliated Oncologists LLC stands firm in their belief in following "Best Practice", evidence based standards of care, providing state of the art treatment, integrating quality, value, and compassionate care for individuals with cancer from diagnosis to survivorship. Dedicated to giving their patients the quality care that they deserve, the company utilizes the latest innovations in the medical industry to implement high quality, value based, and collaborative care.

Cathy serves as an Oncology Healthcare Consultant with intense focus on Adavanced Care Planning, Patient Access, Value based care and Advanced Payment Models.  In this capacity, she also utilizes her expertise and experiences in the areas of healthcare consulting, business development, and strategic planning within assigned regions.  She leads oncology centers in achieving strong financial performance by combining the use of information technology and referral management.  She is instrumental in working toward containing costs, by implementing new services, such as tele-medicine, and assisting in the development of an oncology urgent care center. She specializes in analyzing existing operations and implementing and sustaining viable action plans, to improve performance, physician relations, patient care, sales and more.

To further her professional development, Cathy is certified as a Lean Six Sigma Green Belt. In addition, she is an affiliate of several organizations including the National Advisory Board, IMOS, ASCO, ACCC, National Association of Professional Women, and QOPI.  She also serves as the Administrator and Quality Lead for the Oncology Care Model project at all sites of service.

Throughout the course of her education and training, Cathy attained her Bachelor of Science degree in Healthcare Administration and Management at the University of St. Francis.

Cathy is dedicating this recognition to her mother, Geraldine Bucci and her two children.

For more information, please visit www.mckesson.com

CONTACT: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: